N-[5-(5-Fluoropyridin-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutyramide (SEN78702, WYE-308775): A Medicinal Chemistry Effort toward an α7 Nicotinic Acetylcholine Receptor Agonist Preclinical Candidate

被引：15

作者：

Zanaletti, Riccardo ^{[1
]}

Bettinetti, Laura ^{[1
]}

Castaldo, Cristiana ^{[1
]}

Ceccarelli, Ilaria ^{[1
]}

Cocconcelli, Giuseppe ^{[1
]}

Comery, Thomas A. ^{[2
]}

Dunlop, John ^{[2
]}

Genesio, Eva ^{[1
]}

Ghiron, Chiara ^{[1
]}

Haydar, Simon N. ^{[2
]}

Jow, Flora ^{[2
]}

Maccari, Laura ^{[1
]}

Micco, Iolanda ^{[1
]}

Nencini, Arianna ^{[1
]}

Fratelli, Carmela ^{[1
]}

Scali, Carla ^{[1
]}

Turlizzi, Elisa ^{[1
]}

Valacchi, Michela ^{[1
]}

机构：

[1] Siena Biotech SpA, I-53100 Siena, Italy

[2] Pfizer Inc, Neurosci Res Unit, Groton, CT 06340 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2012年 / 55卷 / 22期

关键词：

DISCOVERY; SCHIZOPHRENIA; RAT;

D O I：

10.1021/jm3013568

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

alpha 7 nicotinic acetylcholine receptors (alpha 7 nAChR) represent promising therapeutic candidates for the treatment of cognitive impairment, associated with Alzheimer's disease (AD) and schizophrenia. A medicinal chemistry effort around previously reported compound 1 (SEN15924, WAY 361789) led to the identification of 12 (SEN78702, WYE-308775) a potent and selective full agonist of the alpha 7 nAChR that demonstrated improved plasma stability, brain levels, and efficacy in behavioral cognition models.

引用

页码：10277 / 10281

页数：5

共 50 条

[21] Discovery of 2-(4-((1H-1,2,4-triazol-1-yl)methyl)-5-(4-bromophenyl)-1-(2-chlorophenyl)-1H-pyrazol-3-yl)-5-tert-butyl-1,3,4-thiadiazole (GCC2680) as a potent, selective and orally efficacious cannabinoid-1 receptor antagonist
Lee, Jinhwa
Seo, Hee Jeong
Lee, Suk Ho
Kim, Jeongmin
Jung, Myung Eun
Lee, Sung-Han
Song, Kwang-Seop
Lee, Junwon
Kang, Suk Youn
Kim, Min Ju
Kim, Mi-Soon
Son, Eun-Jung
Lee, MinWoo
Han, Ho-Kyun
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (17) : 6377 - 6388
[22] Pharmacological and behavioral profile of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-6-chinolincarboxamide (EVP-5141), a novel α7 nicotinic acetylcholine receptor agonist/serotonin 5-HT3 receptor antagonist
Frank G. Boess
Jean de Vry
Christina Erb
Timo Flessner
Martin Hendrix
Joachim Luithle
Christoph Methfessel
Katrin Schnizler
F. Josef van der Staay
Marja van Kampen
Welf-Burkhard Wiese
Gerhard König
Psychopharmacology, 2013, 227 : 1 - 17
[23] Pharmacological and behavioral profile of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-6-chinolincarboxamide (EVP-5141), a novel α7 nicotinic acetylcholine receptor agonist/serotonin 5-HT3 receptor antagonist
Boess, Frank G.
de Vry, Jean
Erb, Christina
Flessner, Timo
Hendrix, Martin
Luithle, Joachim
Methfessel, Christoph
Schnizler, Katrin
van der Staay, F. Josef
van Kampen, Marja
Wiese, Welf-Burkhard
Koenig, Gerhard
PSYCHOPHARMACOLOGY, 2013, 227 (01) : 1 - 17
[24] Synthesis and biological evaluation of N-(3-fluorobenzyl)-4-(1-(methyl-d3)-1H-indazol-5-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-amine as a novel, potent ALK5 receptor inhibitor
Kang, Byung-Nam
Kang, Hong-Jun
Kim, Sunjoo
Lee, Jungwoo
Lee, Jinwoo
Jeong, Hee-Jin
Jeon, Seeun
Shin, Youngdo
Yoon, Cheolhwan
Han, Cheolkyu
Seo, Jeongbeob
Yun, Jaesook
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2023, 85
[25] Discovery of N-((3S,4S)-4-(3,4-Difluorophenyl)piperidin-3-yl)-2-fluoro-4-(1-methyl-1H-pyrazol-5-yl)benzamide (Hu7691), a Potent and Selective Akt Inhibitor That Enables Decrease of Cutaneous Toxicity
Che, Jinxin
Dai, Xiaoyang
Gao, Jian
Sheng, Haichao
Zhan, Wenhu
Lu, Yang
Li, Dan
Gao, Zizheng
Jin, Zegao
Chen, Binhui
Luo, Peihua
Yang, Bo
Hu, Yongzhou
He, Qiaojun
Weng, Qinjie
Dong, Xiaowu
JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (16) : 12163 - 12180
[26] Discovery of 5-(6-[(3R)-1-Azabicyclo[2.2.2]oct-3-yloxy]pyridazin-3-yl)-1H-indole as a novel a7 neuronal nicotinic receptor (NNR) agonist
Li, Tao
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
[27] Discovery of (R)-4-(8-Fluoro-2-oxo-1,2-dihydroquinazolin-3(4H)-yl)-N-(3-(7-methyl-1H-indazol-5-yl)-1-oxo-1-(4-(piperidin-1-yl)piperidin-1-yl)propan-2-yl)piperidine-1-carboxamide (BMS-694153):: A potent antagonist of the human calcitonin gene-related peptide receptor for migraine with rapid and efficient intranasal exposure
Degnan, Andrew P.
Chaturvedula, Prasad V.
Conway, Charles M.
Cook, Deborah A.
Davis, Carl D.
Denton, Rex
Han, Xiaojun
Macci, Robert
Mathias, Neil R.
Moench, Paul
Pin, Sokhoin S.
Ren, Shelly X.
Schartman, Richard
Signor, Laura J.
Thalody, George
Widmann, Kimberly A.
Xu, Cen
Macor, John E.
Dubowchik, Gene M.
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (16) : 4858 - 4861
[28] Synthesis and in vitro characterization of N-[5-(4,5-dihydro-1H-imidazol-2-yl)-2-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl]methanesulfonamide and its enantiomers: A novel selective alpha(1A) receptor agonist
Meyer, MD
Altenbach, RJ
Hancock, AA
Buckner, SA
Knepper, SM
Kerwin, JF
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (20) : 4116 - 4119
[29] Synthetic studies towards isomeric pyrazolopyrimidines as potential ATP synthesis inhibitors of Mycobacterium tuberculosis. Structural correction of reported N-(6-(2-(dimethylamino)ethoxy)-5-fluoropyridin-3-yl)-2-(4-fluorophenyl)-5-(trifluoromethyl)pyrazolo[1,5-α]pyrimidin-7-amine
Choi, Peter J.
Lu, Guo-Liang
Sutherland, Hamish S.
Giddens, Anna C.
Franzblau, Scott G.
Cooper, Christopher B.
Denny, William A.
Palmer, Brian D.
TETRAHEDRON LETTERS, 2022, 90
[30] Inverse agonist properties of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide HCl (SR141716A) and 1-(2-chlorophenyl)-4-cyano-5-(4-methoxypheny-1H-pyrazole-3-carboxylic acid phenylamide (CP-272871) for the CB1 cannabinoid receptor
Meschler, JP
Kraichely, DM
Wilken, GH
Howlett, AC
BIOCHEMICAL PHARMACOLOGY, 2000, 60 (09) : 1315 - 1323

← 1 2 3 4 5 →